Study shows promising results for Chembio's syphilis test

12/16/2012 | GenomeWeb Daily News (free registration)

Chembio Diagnostics reported positive trial results for a point-of-care syphilis test that runs on its Dual Path Platform. The trial, which involved 3,134 samples, found the test was able to detect syphilis antibodies with sensitivities and specificities of 96.7% and 99.3% respectively in whole blood, 96.4% and 99.1% in finger prick blood, 94.6% and 99.6% in blood plasma.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN